... of chemotherapy-resistant malignant melanoma. Because most patients with metastatic melanoma fail to respond to available ... to be tested in the clinic, whether specific types of melanomas will respond better than others, and whether combining mebendazole ...
... Center and lead investigator for the study. "Patients with metastatic melanoma are at high risk for additional metastases ... , 54 patients with regionally recurrent or distant metastatic melanoma were injected with a vaccine that included each ...
... has identified a new method for selectively killing metastatic melanoma cells, which may lead to new areas ... Center. According to Fisher, the pathway that is activated involves the melanoma differentiation associated gene-5, or mda ...
... have identified a new method for selectively killing metastatic melanoma cells, which may lead to new areas for drug development in melanoma -- a cancer that is highly resistant to current treatment ...
... -fighting antibody has extended the lives of patients with metastatic melanoma in a large, international clinical trial ... . "It is the first study to show a survival benefit for metastatic melanoma, which is often a fatal disease, and it is proof ...
... -fighting antibody has extended the lives of patients with metastatic melanoma in a large, international clinical trial. The study's researchers will report their findings simultaneously at the American ...
A therapy that multiplies the effect of a natural disease-fighting antibody has extended the lives of patients with metastatic melanoma in a large, international clinical trial.
... and awful side effects. In diseases like metastatic melanoma, where the prognosis is dismal, it's easy ... the word off the shelf and use it, albeit cautiously. Metastatic melanoma - the not-so-good, bad and ugly ...
... cancer treatment closer to market." The incidence of metastatic melanoma has increased over the last three decades ... , patients must have had stage III or IV (metastatic) melanoma, and must have been previously treated unsuccessfully ...
... and survival despite previous recurrences of widespread metastatic melanoma, , , this is the first complete regression we have observed ... . "These results are extremely encouraging for patients suffering from metastatic melanoma," said Dr. Dillman. "The promise of new ...
... trial of a promising new experimental therapy for metastatic melanoma has shown positive results, including tumor shrinkage in the majority of patients. The positive results ...
... were then transplanted back into hosts and found to eradicate metastatic melanoma for the lifetime of the mice. "We found that the transplantation of gene ... incidence of all 50 states. Current treatments for metastatic melanoma, though exciting and innovative, have been highly ...
... cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing ... used adoptive immunotherapy on treatment-resistant patients with metastatic melanoma who had extensive prior therapy. Of 93 ...
... announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown ...
... Administration announced that the drug ipilimumab (brand name Yervoy) was approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown ...
